Execution Bottlenecks Emerge

Large biological datasets are hard to standardize, de-identify, license, and merge across public, academic, and commercial sources. The initiative remains alive, but the first-year deliverables fall short of the headline ambition.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.